Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms—An In Vitro StudyShota Fukuda(Kindai University), Yasuhiro Tsutani(Hiroshima University)BiomedicinesJune 25, 202410.3390/biomedicines12071412Cited by 11SaveCiteExport RISWatch citationsRelated PapersEfficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro Study|Cells|2025|1Efficacy of Novel Third-Generation Tyrosine Kinase Inhibitors for Uncommon <em>EGFR</em> Mutations – an In Vitro Study|Preprints.org|2025|0